Experimental Drug Found to Slow Progression of MS-Related Disability
A new experimental drug is showing promise in slowing the progression of disability in individuals with multiple sclerosis (MS), according to recent findings from a large clinical trial. The results have sparked optimism among patients, neurologists, and researchers alike, as current treatment options for MS often focus primarily on managing symptoms rather than significantly altering the course of the disease.